Eli Lilly News 16 September 2025

Big Pharma’s Billion-Dollar Bet: Inside Eli Lilly’s $5B Virginia Factory and America’s New Drug Manufacturing Boom

Eli Lilly Stock Surges on Obesity-Drug Boom – Is $1,000 Next?

Stock Market Performance In early October 2025, Eli Lilly (NYSE: LLY) stock leapt upward. After closing around $726 on Sept. 29 and ~$763 on Sept. 30 nasdaq.com, it spiked to about $832 intraday on

1 October 2025

Eli Lilly’s Weight-Loss Pill Sheds Pounds Fast—But Hits a Plateau: What New Trial Results Mean for the Obesity Drug Race

Trial Results: Big Early Losses, Then Weight Loss Levels Off This highly anticipated trial put Lilly’s oral GLP-1 drug, orforglipron, to the test in a large group of adults struggling with obesity.

17 September 2025

Clinical Trials · Eli Lilly · NYSE:LLY · NYSE:NVO · Obesity Drugs · Pharma News · Weight Loss

Big Pharma’s Billion-Dollar Bet: Inside Eli Lilly’s $5B Virginia Factory and America’s New Drug Manufacturing Boom

Richmond’s New Pharma Giant: Overview of Lilly’s $5B Factory Eli Lilly’s forthcoming Richmond-area factory is set to be one of the largest and most advanced pharmaceutical manufacturing sites in the world. At

16 September 2025

Drug Industry · Eli Lilly · Innovation · Manufacturing · NASDAQ:AZN · NYSE:JNJ · NYSE:LLY · NYSE:NVS · NYSE:SNY · Pharmaceuticals

Eli Lilly News 16 September 2025 - 1 October 2025

Eli Lilly Stock Surges on Obesity-Drug Boom – Is $1,000 Next?

Eli Lilly’s Weight-Loss Pill Sheds Pounds Fast—But Hits a Plateau: What New Trial Results Mean for the Obesity Drug Race

Big Pharma’s Billion-Dollar Bet: Inside Eli Lilly’s $5B Virginia Factory and America’s New Drug Manufacturing Boom